Sofinnova Partners is a leading European venture capital firm specializing in life sciences, healthcare, and sustainability. Founded in 1972 and headquartered in Paris, it acts as a hands-on company builder across the entire value chain of life sciences investments, from incubation through later-stage growth.
46% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $70.4M (across 282 rounds with reported amounts).
Portfolio
264
Fund Size
$750M
Top Stage
Series A
Last 12 Mo
22
Team
David Evans
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
459 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Aiolos | Series A | $245M | Sep 2026 |
 NextCure | Series B | $500M | Aug 2026 |
 Mironid | Series B | $46M | Aug 2026 |
 City Therapeutics | Series B | $99.5M | Jun 2026 |
| IIngenix | Seed | — | Jun 2026 |
| PP2 Science Inc. | Unknown | $23M | May 2026 |
 Coultreon Biopharma | Series A | $125M | Apr 2026 |
 Coultreon Biopharma | Series A | $125M | Apr 2026 |
 Verley | Series A | — | Feb 2026 |
 Verley | Series A | — | Feb 2026 |
 Neurent Medical | Series C | $74M | Feb 2026 |
 Tenpoint Therapeutics | Series B | — | Jan 2026 |
 BrightHeart | Series A | — | Jan 2026 |
 Mediar | Series B | $76M | Jan 2026 |
| CClaris Bio | Series B | $57M | Jan 2026 |
| NNanoPhoria | Series A | — | Jan 2026 |
| Coultreon Biopharma | Series A | $125M | Jan 2026 |
| Coultreon Biopharma | Series A | $125M | Jan 2026 |
| IIngenix | Seed | — | Jan 2026 |
 Claris | Series B | $118M | Jan 2026 |
 Artios | Series D | $115M | Nov 2025 |
 myTomorrows | Growth | $29M | Nov 2025 |
 AAVantgarde Bio | Series B | — | Nov 2025 |
| HHemab | Series C | $157M | Oct 2025 |
 Elevara Medicines | Series A | $70M | Oct 2025 |
Page 1 of 19
Top Co-Investors
Forbion43 shared
OrbiMed34 shared
Pfizer Ventures31 shared
Bpifrance31 shared
Novo Capital30 shared
Alexandria Venture Investments28 shared
Cormorant Asset Management28 shared
Novo Holdings A/S26 shared
RA Capital Management25 shared
The Invus Group, LLC23 shared
Surveyor Capital20 shared
Atlas Venture19 shared
M Ventures19 shared
New Enterprise Associates19 shared
Rock Springs Capital18 shared
T. Rowe Price18 shared
Andera Partners18 shared
EQT Life Sciences17 shared
F-Prime Capital17 shared
Venrock17 shared
Last updated: 20 October 2026